A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Sievers, M.D.
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rocky Mountain Cancer Center
Denver, Colorado, United States
- Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
- Indiana Oncology-Hematology Consultants
Indianapolis, Indiana, United States
- University of Massachusetts Medical Center
Worcester, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- St. Vincent'S Comprehensive Cancer Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Cancer Center of the Carolinas
Greenville, South Carolina, United States
- Scott & White Memorial Hospital
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2005
- Primary completion
- 31 Jan 2010
- Completion
- 31 Jan 2010
- Last update posted
- 18 Dec 2014
- Registered enrollment
- 82
- Registry id
- NCT00283114
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.